Skip to main content
13 August 2026
02 May 2025

CellBio Scientific Acquires BioChain to Expand Biospecimen and Research Solutions

CellBio Scientific, a premier provider of life science tools, research services, and clinical solutions, announced the acquisition of BioChain, a leading provider of biospecimen collection, preparation, and analysis. The acquisition strengthens CellBio Scientific's platform at a pivotal moment in drug discovery and d…

29 April 2025

Oramed Completes Strategic Investment in Alpha Tau Medical

Oramed Pharmaceuticals Inc., a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection, announced that it has successfully closed a strategic investment in Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT. As part…

22 April 2025

Jazz Pharmaceuticals Seals $935M Chimerix Acquisition, Boosting Oncology Pipeline

Jazz Pharmaceuticals plc announced the successful completion of its acquisition of Chimerix, Inc. ("Chimerix") for approximately $935 million in cash. Chimerix is now a wholly owned subsidiary of Jazz. "Bringing Chimerix into Jazz adds a novel medicine to our oncology portfolio and advances our efforts to address unm…

17 April 2025

Chime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, is pleased to announce a strategic cooperation agreement with Polpharma Biologics to advance the end-to-end development and manufacture of a biosimilar product for the global market. This partnership underscores Chime Biologics' co…

16 April 2025

Illumina and Tempus Partner to Advance AI-Driven Precision Medicine

Illumina Inc. a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation. The collaboration will combine leading Illumina AI technologies with Tempus's co…

16 April 2025

Lonza Joins CMAC to Advance Particle Technologies and Drug Product Development

Lonza, a global development and manufacturing partner to the pharmaceutical and biotech markets, announced it has joined CMAC, a world leading centre for medicines manufacturing research, to enhance its service offering for particle technologies and drug product development and manufacture.  Based at the University o…

09 April 2025

AGC Biologics Strengthens its Single Use Bioreactors Facility in Japan

 AGC Biologics announced a strategic decision about the large-scale single-use technology it will use at its new Yokohama, Japan facility. The CDMO is introducing two 5,000 L Thermo Scientific DynaDrive Single-Use Bioreactors (S.U.B.), which makes the site one of the most advanced in Japan for large-scale mammalian-ba…

01 April 2025

Veltris Acquires BPK Technologies to Expand Digital Engineering & AI Capabilities

Veltris, a digital product engineering services provider backed by Trive Capital and BayLink Capital is pleased to announce the acquisition of BPK Technologies . This acquisition advances Veltris' strategic direction towards industry solutions and expands its digital engineering and data/AI capabilities to help client…

Page 35 of 37